Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Sabri

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Nuklearmedizin. Nuclear Medicine|May 30, 1998
[Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease]O Sabri, G Schulz, M Zimny, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2013
Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancerK Kubiessa, S Purz, M Gawlitza, et al.
Nuklearmedizin. Nuclear Medicine|October 3, 2013
[Perfusion brain imaging with SPECT-technique. German Guideline S1]T Kranert, C Menzel, P Bartenstein, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 31, 2007
Norchloro-fluoro-homoepibatidine (NCFHEB) - a promising radioligand for neuroimaging nicotinic acetylcholine receptors with PETW Deuther-Conrad, J T Patt, P R Lockman, et al.
Dementia and Geriatric Cognitive Disorders|July 21, 2012
Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's diseaseC G Schipke, O Peters, I Heuser, et al.
Scientific Reports|December 11, 2023
Prevention of activated brown adipose tissue on <sup>18</sup>F-FDG-PET scans of young lymphoma patients: results of an ancillary study within the EuroNet-PHL-C2 trialC Pötzsch, Lars Kurch, S Naumann, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 1995
[Effect of morphological changes on perfusion and metabolism in cerebral microangiopathy. A comparison of PET, SPECT, and magnetic resonance imaging findings]O Sabri, D Hellwig, H J Kaiser, et al.
European Radiology|June 21, 2017
Comparison of volumetric and functional parameters in simultaneous cardiac PET/MR: feasibility of volumetric assessment with residual activity from prior PET/CTC Lücke, B Oppolzer, P Werner, et al.
Nuklearmedizin. Nuclear Medicine|April 18, 2000
One-year follow-up of neuropsychology, MRI, rCBF and glucose metabolism (rMRGlu) in cerebral microangiopathyO Sabri, D Hellwig, M Schreckenberger, et al.
EJNMMI Research|July 3, 2021
Whole-body [<sup>18</sup>F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluationL Kurch, R Kluge, O Sabri, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Nuklearmedizin. Nuclear Medicine|May 30, 1998
[Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease]O Sabri, G Schulz, M Zimny, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2013
Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancerK Kubiessa, S Purz, M Gawlitza, et al.
Nuklearmedizin. Nuclear Medicine|October 3, 2013
[Perfusion brain imaging with SPECT-technique. German Guideline S1]T Kranert, C Menzel, P Bartenstein, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 31, 2007
Norchloro-fluoro-homoepibatidine (NCFHEB) - a promising radioligand for neuroimaging nicotinic acetylcholine receptors with PETW Deuther-Conrad, J T Patt, P R Lockman, et al.
Dementia and Geriatric Cognitive Disorders|July 21, 2012
Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's diseaseC G Schipke, O Peters, I Heuser, et al.
Scientific Reports|December 11, 2023
Prevention of activated brown adipose tissue on <sup>18</sup>F-FDG-PET scans of young lymphoma patients: results of an ancillary study within the EuroNet-PHL-C2 trialC Pötzsch, Lars Kurch, S Naumann, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 1995
[Effect of morphological changes on perfusion and metabolism in cerebral microangiopathy. A comparison of PET, SPECT, and magnetic resonance imaging findings]O Sabri, D Hellwig, H J Kaiser, et al.
European Radiology|June 21, 2017
Comparison of volumetric and functional parameters in simultaneous cardiac PET/MR: feasibility of volumetric assessment with residual activity from prior PET/CTC Lücke, B Oppolzer, P Werner, et al.
Nuklearmedizin. Nuclear Medicine|April 18, 2000
One-year follow-up of neuropsychology, MRI, rCBF and glucose metabolism (rMRGlu) in cerebral microangiopathyO Sabri, D Hellwig, M Schreckenberger, et al.
EJNMMI Research|July 3, 2021
Whole-body [<sup>18</sup>F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluationL Kurch, R Kluge, O Sabri, et al.
Pageof 12